Sort
10,766 grants matching “checkpoint inhibitor”
Large-Scale Genetic Analyses of Human Cancer
$310,729Victor E Velculescu · Johns Hopkins University · R01 · FY2018 · CA
Immunopathology Core
$310,662Cecilia C Yeung · University Of Washington · P01 · FY2025 · CA
P38, G2 Arrest, and Temozolomide Resistance in Gliomas
$310,575University Of California San Francisco · R01 · FY2004 · CA
The Role of Egfl6 in Tumor Immunity
$310,336Sandra Cascio · Magee-Women'S Res Inst And Foundation · R01 · FY2025 · CA
The Mammalian Cell Cycle Control and Tumor Genesis
$310,250University Of North Carolina Chapel Hill · R01 · FY2005 · CA
Structure and Function of the Essential Cell Cycle Regulator Cdc34
$310,000Shaun Olsen · University Of Texas Hlth Science Center · R01 · FY2022 · GM
Therapeutic targeting of stratifin structure and function
$309,964Jian-Ting Zhang · Indiana University Indianapolis · R01 · FY2011 · CA
Therapeutic targeting of stratifin structure and function
$309,964Jian-Ting Zhang · Indiana University Indianapolis · R01 · FY2012 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$309,948Elad Ziv · University Of California, San Francisco · R01 · FY2023 · CA
Role of RecQ Helicases to Prevent Senescence By c-Myc
$309,930Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2007 · AG
53BP1-Mediated Regulation of DNA Repair and Chemoresistance
$309,504Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2013 · CA
Project 2: Targeting Immune Vulnerabilities in Lung Cancer
$309,392John V. Heymach · Ut Southwestern Medical Center · P50 · FY2024 · CA
Structure and Function of the Essential Cell Cycle Regulator Cdc34
$309,000Shaun Olsen · University Of Texas Hlth Science Center · R01 · FY2021 · GM
Project 1: Targeting Neutrophils to Enhance ICI Efficacy in NSCLC
$308,964A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2025 · CA
Mechanisms of Telomere Function
$308,820New York University School Of Medicine · R01 · FY2005 · CA
A novel monoclonal antibody-based anti-NK cell anti-inflammatory strategy for treating autoimmune and checkpoint inhibitor induced myocarditis
$308,650Dror Luger · Inflamma Therapeutics, Llc · R43 · FY2021 · HL
Targeting Cell Cycle Machinery For Cancer Therapy
$308,525Temple University · R01 · FY2005 · CA
Targeting Cell Cycle Machinery For Cancer Therapy
$308,525Temple University · R01 · FY2004 · CA
Mechanism(s) of Hepatocyte Transformation by the Hepatitis B Virus X Protein
$308,439Ourania M. Andrisani · Purdue University · R01 · FY2013 · DK
Mrad9 Radioresistance Gene
$308,410Columbia University Health Sciences · R01 · FY2004 · CA
Mrad9 Radioresistance Gene
$308,410Columbia University Health Sciences · R01 · FY2003 · CA
Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer
$308,399Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R34 · FY2025 · CA
Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM
$308,393E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2017 · CA
PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy
$308,387Eric S Ubil · University Of Alabama At Birmingham · R01 · FY2022 · CA
XLF in double-strand break repair and chemo/radiosensitization
$308,039Lawrence F Povirk · Virginia Commonwealth University · R01 · FY2015 · CA